Responding to organ failure in HIV-infected patientsROLAND, Michelle E; HAVLIR, Diane V.The New England journal of medicine. 2003, Vol 348, Num 23, pp 2279-2281, issn 0028-4793, 3 p.Article

Atazanavir : New option for treatment of HIV infectionHAVLIR, Diane V; O'MARRO, Steven D.Clinical infectious diseases. 2004, Vol 38, Num 11, pp 1599-1604, issn 1058-4838, 6 p.Article

Nontuberculous mycobacteria in the HIV infected patientJONES, Denis; HAVLIR, Diane V.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, vii, 665-674 [10 p.]Article

Tuberculosis Drug Development: Ensuring People Living with HIV Are Not Left BehindLUETKEMEYER, Anne F; GETAHUN, Haileyesus; CHAMIE, Gabriel et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 10, pp 1107-1113, issn 1073-449X, 7 p.Article

Changes in the Timing of Antiretroviral Therapy Initiation in HIV-Infected Patients With Tuberculosis in Uganda: A Study of the Diffusion of Evidence Into Practice in the Global Response to HIV/AIDSVIJAYAN, Tara; SEMITALA, Fred C; MATSIKO, Nicholas et al.Clinical infectious diseases. 2013, Vol 57, Num 12, pp 1766-1772, issn 1058-4838, 7 p.Article

Tuberculosis as Part of the Natural History of HIV Infection in Developing CountriesCHAMIE, Gabriel; LUETKEMEYER, Annie; CHARLEBOIS, Edwin et al.Clinical infectious diseases. 2010, Vol 50, issn 1058-4838, S245-S254, SUP3Article

Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjectsHAVLIR, Diane V; SCHRIER, Rachel D; TORRIANI, Francesca J et al.The Journal of infectious diseases. 2000, Vol 182, Num 6, pp 1658-1663, issn 0022-1899Article

The case for earlier treatment of HIV infection. Editorial commentaryHOLMBERG, Scott D; PALELLA, Frank J; LICHTENSTEIN, Kenneth A et al.Clinical infectious diseases. 2004, Vol 39, Num 11, pp 1699-1708, issn 1058-4838, 10 p.Article

Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapyBENNETT, Kara K; DEGRUTTOLA, Victor G; MARSCHNER, Ian C et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, Num 1, pp 20-26, issn 1525-4135, 7 p.Article

The Distribution of HIV DNA and RNA in Cell Subsets Differs in Gut and Blood of HIV-Positive Patients on ART: Implications for Viral PersistenceYUKL, Steven A; SHERGILL, Amandeep K; HAVLIR, Diane V et al.The Journal of infectious diseases. 2013, Vol 208, Num 8, pp 1212-1220, issn 0022-1899, 9 p.Article

Early Virologic Failure and the Development of Antiretroviral Drug Resistance Mutations in HIV-Infected Ugandan ChildrenRUEL, Theodore D; KAMYA, Moses R; ACHAN, Jane et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 56, Num 1, pp 44-50, issn 1525-4135, 7 p.Article

Detection of Nonnudeoside Reverse-Transcriptase Inhibitor-Resistant HIV-1 after Discontinuation of Virologically Suppressive Antiretroviral TherapyHARE, C. Bradley; MELLORS, John; AWEEKA, Francesca et al.Clinical infectious diseases. 2008, Vol 47, Num 3, pp 421-424, issn 1058-4838, 4 p.Article

Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudineHAVLIR, Diane V; KOELSCH, Kersten K; STRAIN, Matthew C et al.The Journal of infectious diseases. 2005, Vol 191, Num 7, pp 1164-1168, issn 0022-1899, 5 p.Article

Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patientsZHOU, Xiao-Jian; HAVLIR, Diane V; RICHMAN, Douglas D et al.AIDS (London). 2000, Vol 14, Num 18, pp 2869-2876, issn 0269-9370Article

Assessment of Population-Based HIV RNA Levels in a Rural East African Setting Using a Fingerprick-Based Blood Collection MethodJAIN, Vivek; LIEGLER, Teri; SONAWANE, Nitin et al.Clinical infectious diseases. 2013, Vol 56, Num 4, pp 598-605, issn 1058-4838, 8 p.Article

Neonatal Mortality in HIV-Exposed Infants Born to Women Receiving Combination Antiretroviral Therapy in Rural UgandaADES, Veronica; MWESIGWA, Julia; RUEL, Theodore D et al.Journal of tropical pediatrics (1980). 2013, Vol 59, Num 6, pp 441-446, issn 0142-6338, 6 p.Article

The Effect of AIDS Clinical Trials Group Protocol 5164 on the Time From Pneumocystis jirovecii Pneumonia Diagnosis to Antiretroviral Initiation in Routine Clinical Practice: A Case Study of Diffusion, Dissemination, and ImplementationGENG, Elvin H; KAHN, James S; CHANG, Olivia C et al.Clinical infectious diseases. 2011, Vol 53, Num 10, pp 1008-1014, issn 1058-4838, 7 p.Article

Short-Term Risk of HIV Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral TherapyCHARLEBOIS, Edwin D; RUEL, Theodore D; KAMYA, Moses R et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 3, pp 330-335, issn 1525-4135, 6 p.Article

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitorsparing regimens for initial HIV treatmentHAUBRICH, Richard H; RIDDLER, Sharon A; MELLORS, John W et al.AIDS (London). 2009, Vol 23, Num 9, pp 1109-1118, issn 0269-9370, 10 p.Article

Polymerase Chain Reaction of secAl on Sputum or Oral Wash Samples for the Diagnosis of Pulmonary TuberculosisDAVIS, J. Lucian; HUANG, Laurence; HUBER, Charles et al.Clinical infectious diseases. 2009, Vol 48, Num 6, pp 725-732, issn 1058-4838, 8 p.Article

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. CommentaryBLANKSON, Joel N; SILICIANO, Janet D; NGUYEN, Juin et al.The Journal of infectious diseases. 2005, Vol 191, Num 9, pp 1394-1396, issn 0022-1899, 12 p.Article

Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex diseaseHAVLIR, Diane V; TORRIANI, Francesca J; SCHRIER, Rachel D et al.Journal of clinical microbiology (Print). 2001, Vol 39, Num 1, pp 298-303, issn 0095-1137Article

Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trialKAMYA, Moses R; KAPISI, James; JAGANNATHAN, Prasanna et al.AIDS (London). 2014, Vol 28, Num 18, pp 2701-2709, issn 0269-9370, 9 p.Article

Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE StudyLUETKEMEYER, Anne F; ROSENKRANZ, Susan L; HAVLIR, Diane V et al.Clinical infectious diseases. 2013, Vol 57, Num 4, pp 586-593, issn 1058-4838, 8 p.Article

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infectionHAUBRICH, Richard H; RIDDLER, Sharon A; RIBAUDO, Heather et al.AIDS (London). 2011, Vol 25, Num 18, pp 2269-2278, issn 0269-9370, 10 p.Article